NCT05723640 2025-09-08
The Safety and Dosimetry Study of 177Lu-LNC1004 Injection
Yantai LNC Biotechnology Singapore PTE. LTD.
Phase 1 Completed
Clinical Trials
3 trialsNCT03628677 2025-02-04
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Arcus Biosciences, Inc.
Phase 1 Completed
NCT03318445 2021-03-04
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
University of California, San Francisco
Phase 1 Completed